Retinoic acid inducible gene-I and mda-5 are involved in influenza A virus-induced expression of antiviral cytokines

Microbes and Infection

Volumn 8, Issue 8, 2006, Pages 2013-2020

  Sirén, Jukka ^a   Imaizumi, Tadaatsu ^b   Sarkar, Devanand ^c   Pietilä, Taija ^a   Noah, Diana L ^d   Lin, Rongtuan ^e   Hiscott, John ^e   Krug, Robert M ^d   Fisher, Paul B ^c   Julkunen, Ilkka ^a   Matikainen, Sampsa ^a,f  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b HIROSAKI UNIVERSITY   (Japan)

^c NewYork Presbyterian Hospital   (United States)

^d UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^e MCGILL UNIVERSITY   (Canada)

^f FINNISH INSTITUTE OF OCCUPATIONAL HEALTH   (Finland)

Author keywords

Epithelial cell; Influenza virus; Interferon; mda 5; RIG I

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; CYTOKINE; DOUBLE STRANDED RNA; INTERLEUKIN DERIVATIVE; MESSENGER RNA; RETINOIC ACID DERIVATIVE; RNA HELICASE; TOLL LIKE RECEPTOR 3;

ANIMAL CELL; ARTICLE; CELL LINE; CELL TYPE; DENDRITIC CELL; EPITHELIUM CELL; GENE CONSTRUCT; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; HOST CELL; HUMAN; HUMAN CELL; INFLUENZA VIRUS A; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRUS INFECTION; VIRUS STRAIN;

CYTOKINES; DEAD-BOX RNA HELICASES; DENDRITIC CELLS; EPITHELIAL CELLS; GENE EXPRESSION REGULATION; HUMANS; INFLUENZA A VIRUS; INFLUENZA A VIRUS, H3N2 SUBTYPE; PROTEINS; RNA, MESSENGER; TRANSCRIPTION FACTORS;

INFLUENZA A VIRUS; ORTHOMYXOVIRIDAE;

EID: 33748192461     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2006.02.028     Document Type: Article

References (53)

1. Bowie A.G., and Haga I.R. The role of Toll-like receptors in the host response to viruses. Mol. Immunol. 42 (2005) 859-867
2. Mogensen T.H., and Paludan S.R. Reading the viral signature by Toll-like receptors and other pattern recognition receptors. J. Mol. Med. 83 (2005) 180-192
3. Tissari J., Sirén J., Meri S., Julkunen I., and Matikainen S. IFN-α enhances TLR3-mediated antiviral cytokine expression in human endothelial and epithelial cells by up-regulating TLR3 expression. J. Immunol. 174 (2005) 4289-4294
4. Miettinen M., Sareneva T., Julkunen I., and Matikainen S. IFNs activate Toll-like receptor gene expression in viral infections. Genes Immun. 2 (2001) 349-355
5. Alexopoulou L., Holt A.C., Medzhitov R., and Flavell R.A. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 43 (2001) 732-738
6. Yoneyama M., Kikuchi M., Natsukawa T., Shinobu N., Imaizumi T., Miyagishi M., Taira K., Akira S., and Fujita T. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat. Immunol. 5 (2004) 730-737
7. Andrejeva J., Childs K.S., Young D.F., Carlos T.S., Stock T.N., Goodbourn S.R., and Randall E. The V proteins of paramyxoviruses bind the IFN-inducible RNA helicase, mda-5, and inhibit its activation of the IFN-beta promoter. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 17264-17269
8. Kang D.C., Gopalkrishnan R.V., Wu Q., Jankowsky Q.E., Pyle A.M., and Fisher P.B. mda-5: An interferon-inducible putative RNA helicase with double-stranded RNA-dependent ATPase activity and melanoma growth-suppressive properties. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 637-642
9. Kang D.C., Gopalkrishnan R.V., Lin L., Randolph A., Valerie K., Pestka S., and Fisher P.B. Expression analysis and genomic characterization of human melanoma differentiation associated gene-5, mda-5: a novel type I interferon-responsive apoptosis-inducing gene. Oncogene 23 (2004) 1789-1800
10. Matsumoto M., Funami K., Tanabe M., Oshiumi H., Shingai M., Seto Y., and Yamamoto A. Subcellular localization of Toll-like receptor 3 in human dendritic cells. J. Immunol. 171 (2003) 3154-3162
11. Dunne A., and O'Neill L.A. Adaptor usage and Toll-like receptor signaling specificity. FEBS Lett. 579 (2005) 3330-3335
12. Seth R.B., Sun L., Ea C.K., and Chen Z.J. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell 122 (2005) 669-682
13. Xu L.G., Wang Y.Y., Han K.J., Li L.Y., Zhai Z., and Shu H.B. VISA is an adapter protein required for virus-triggered IFN-beta Signaling. Mol. Cell 19 (2005) 727-740
14. Kawai T., Takahashi K., Sato S., Coban C., kumar H., Kato H., Ishii K.J., Takeuchi O., and Akira S. IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat. Immunol. 6 (2005) 1074-1076
15. Meylan E., Curran J., Hofmann K., Moradpour D., Binder M., Bartenschlager R., and Tschopp J. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 437 (2005) 1167-1172
16. Sharma S., tenOever B.R., Grandvaux N., Zhou G.P., Lin R., and Hiscott J. Triggering the interferon antiviral response through an IKK-related pathway. Science 300 (2003) 1148-1151
17. Fitzgerald K.A., McWhirter S.M., Faia K.L., Rowe D.C., Latz E., Golenbock D.T., Coyle A.J., Liao S.M., and Maniatis T. IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat. Immunol. 4 (2003) 491-496
18. Sirén J., Pirhonen J., Julkunen I., and Matikainen S. IFN-α regulates TLR-dependent gene expression of IFN-α, IFN-β, IL-28 and IL-29. J. Immunol. 174 (2005) 1932-1937
19. Noah D.L., Twu K.Y., and Krug R.M. Cellular antiviral responses against influenza A virus are countered at the posttranscriptional level by the viral NS1A protein via its binding to a cellular protein required for the 3′ end processing of cellular pre-mRNAs. Virology 307 (2003) 386-395
20. Pirhonen J., Sareneva T., Kurimoto M., Julkunen I., and Matikainen S. Virus infection activates IL-1β and IL-18 production in human macrophages by a caspase-1-dependent pathway. J. Immunol. 162 (1999) 7322-7329
21. Veckman V., Miettinen M., Pirhonen J., Sirén J., Matikainen S., and Julkunen I. Streptococcus pyogenes and Lactobacillus rhamnosus differentially induce maturation and production of Th1-type cytokines and chemokines in human monocyte-derived dendritic cells. J. Leukoc. Biol. 75 (2004) 764-771
22. Ronni T., Matikainen S., Sareneva T., Melen K., Pirhonen J., Keskinen P., and Julkunen I. Regulation of IFN-α/β, MxA, 2′,5′-oligoadenylate synthetase, and HLA gene expression in influenza A-infected human lung epithelial cells. J. Immunol. 158 (1997) 2363-2374
23. Imaizumi T., Aratani S., Nakajima T., Carlson M., Matsumiya T., Tanji K., and Ookawa K. Retinoic acid-inducible gene-I is induced in endothelial cells by LPS and regulates expression of COX-2. Biochem. Biophys. Res. Commun. 292 (2002) 274-279
24. L. Lin, Z.-Z. Su, I.V. Lebedeva, P. Gupta, H. Boukerche, G. Barber, P. Dent, D. Sarkar, P.B. Fisher, Activation of Ras/Raf protects cells from melanoma differentiation associated gene-5 (mda-5)-induced apoptosis, Cell Death Differ. (2006) in press.
25. Lin R., Genin P., Mamane Y., and Hiscott J. Selective DNA binding and association with the CREB binding protein coactivator contribute to differential activation of α/β interferon genes by interferon regulatory factors 3 and 7. Mol. Cell. Biol. 20 (2000) 6342-6353
26. Servant M.J., Grandvaux N., tenOever B.R., Duguay D., Lin R., and Hiscott J. Identification of the minimal phosphoacceptor site required for in vivo activation of interferon regulatory factor 3 in response to virus and double-stranded RNA. J. Biol. Chem. 278 (2003) 9441-9447
27. Sheppard P., Kindsvogel W., Xu W., Henderson K., Schlutsmeyer S., Whitmore T.E., Kuestner R., Garrigues U., Birks C., Roraback J., Ostrander C., Dong D., Shin J., Presnell S., Fox B., Haldeman B., Cooper E., Taft D., Gilbert T., Grant F.J., Tackett M., Krivan W., McKnight G., Glegg C., Foster D., and Klucher K.M. IL-28, IL-29 and their class II cytokine receptor IL-28R. Nat. Immunol. 4 (2003) 63-68
28. Kotenko S.V., Gallagher G., Baurin V.V., Lewis-Antes A., Shen M., Shah N.K., Langer J.A., Sheikh F., Dickensheet H., and Donnelly R.P. IFN-γs mediate antiviral protection through a distinct class II cytokine receptor complex. Nat Immunol. 4 (2003) 69-77
29. Marie I., Durbin J.E., and Levy D.E. Differential viral induction of distinct interferon-α genes by positive feedback through interferon regulatory factor-7. EMBO J. 17 (1998) 6660-6669
30. Tabeta K., Georgel P., Janssen E., Du X., Hoebe K., Crozat K., Mudd S., Shamel L., Sovath S., Goode J., Alexopolou L., Flavell R.A., and Beutler B. Toll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infection. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 3516-3521
31. Kurt-Jones E.A., Chan M., Zhou S., Wang J., Reed G., Bronson R., Arnold M.M., Knipe D.M., and Finberg R.W. Herpes simplex virus 1 interaction with Toll-like receptor 2 contributes to lethal encephalitis. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 1315-1320
32. Kurt-Jones E.A., Popova L., Kwinn L., Haynes L.M., Jones L.P., Tripp R.A., Walsh E.E., Freeman M.W., Golenbock D.T., Andersson L.J., and Finberg R.W. Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat. Immunol. 1 (2000) 398-401
33. Bieback K., Lien E., Klagge I.M., Avota E., Schneider-Schaulies J., Duprex W.P., Wagner H., Kirschning C.J., Ter Meulen V., and Schneider-Schaulies S. Hemagglutinin protein of wild-type measles virus activates Toll-like receptor 2 signaling. J. Virol. 76 (2002) 8729-8736
34. Diebold S.S., Kaisho T., Hemmi H., Akira S., and Reis E.S.C. Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 303 (2004) 1529-1531
35. Heil F., Hemmi H., Hochrein H., Ampenberger F., Kirschning C., Akira S., Lipford G., Wagner H., and Bauer S. Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science 303 (2004) 1526-1529
36. Lund J.M., Alexopoulou L., Sato A., Karow M., Adams N.C., Gale N.W., Iwasaki A., and Flavell R.A. Recognition of single-stranded RNA viruses by Toll-like receptor 7. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 5558-5603
37. Lund J., Sato A., Akira S., Medzhitov R., and Iwasaki A. Toll-like receptor 9-mediated recognition of Herpes simplex virus-2 by plasmacytoid dendritic cells. J. Exp. Med. 198 (2003) 513-520
38. Breiman A., Grandvaux N., Lin R., Ottone C., Akira S., Yoneyama M., Fujita T., Hiscott J., and Meurs E.F. Inhibition of RIG-I-dependent signaling to the interferon pathway during hepatitis C virus expression and restoration of signaling by IKKepsilon. J. Virol. 79 (2005) 3969-3978
39. Foy E., Li K., Sumpter Jr. R., Loo Y.M., Johnson C.L., Wang C., Fish P., Yoneyama M., Fujita T., Lemon S.M., and Gale Jr. M. Control of antiviral defenses through hepatitis C virus disruption of retinoic acid-inducible gene-I signaling. Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 2986-2991
40. Sumpter Jr. R., Loo Y.M., Foy E., Li K., Yoneyama M., Fujita T., Lemon S.M., and Gale Jr. M. Regulating intracellular antiviral defense and permissiveness to hepatitis C virus RNA replication through a cellular RNA helicase, RIG-I. J. Virol. 79 (2005) 2689-2699
41. Melchjorsen J., Beck S., Malmgaard L., Rasmussen S.B., Weber F., Bowie A.G., Matikainen S., and Paludan S.R. Activation of innate defense against a paramyxovirus is mediated by RIG-I and Toll-like receptor 7 and 8 in a cell-type specific manner. J. Virol. 79 (2005) 12944-12951
42. Kato H., Sato S., Yoneyama M., Yamamoto M., Uematsu S., Matsui K., Tsujimura T., Takeda K., Fujita T., Takeuchi O., and Akira S. Cell type-specific involvement of RIG-I in antiviral response. Immunity 23 (2005) 19-28
43. Yoneyama M., Kikuchi M., Matsumoto M., Imaizumi T., Miyagishi M., Taira K., Foy E., Loo Y.M., Gale Jr. M., Akira S., Yonehara S., Kato A., and Fujita T. Shared and unique functions of the DExD/H-box helicases RIG-I, MDA5, and LGP2 in antiviral innate immunity. J. Immunol. 175 (2005) 2851-2858
44. Chang T.H., Liao C.L., and Lin Y.L. Flavivirus induces interferon-beta gene expression through a pathway involving RIG-I-dependent IRF-3 and PI3K-dependent NF-kappaB activation. Microbes Infect. 8 (2006) 157-171
45. Cella M., Jarossay D., Facchetti F., Alebardi O., Nakajima H., Lanzavecchia A., and Colonna M. Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon. Nat. Med. 5 (1999) 919-923
46. Siegal F.P., Kadowaki N., Shodell M., Fitzgerald-Bocarsly P.A., Shah K., Ho S., Antonenko S., and Liu Y.J. The nature of the principal type 1 interferon-producing cells in human blood. Science 284 (1999) 1835-1837
47. Coccia E.M., Severa M., Giacomini E., Monneron D., Remoli M.E., Julkunen I., Cella M., Lande R., and Uze G. Viral infection and Toll-like receptor agonists induce a differential expression of type I and lambda interferons in human plasmacytoid and monocyte-derived dendritic cells. Eur. J. Immunol. 34 (2004) 796-805
48. Lin R., Heylbroeck C., Pitha C.P.M., and Hiscott J. Virus-dependent phosphorylation of the IRF-3 transcription factor regulates nuclear translocation, transactivation potential, and proteasome-mediated degradation. Mol. Cell. Biol. 18 (1998) 2986-2996
49. Yoneyama M., Suhara, Fukuhara W.Y., Fukuda M., Nishida E., and Fujita T. Direct triggering of the type I interferon system by virus infection: activation of a transcription factor complex containing IRF-3 and CBP/p300. EMBO J. 17 (1998) 1087-1095
50. Wathelet M.G., Lin C.H., Parekh B.S., Ronco L.V., Howley P.M., and Maniatis T. Virus infection induces the assembly of coordinately activated transcription factors on the IFN-beta enhancer in vivo. Mol. Cell 1 (1998) 507-518
51. Weaver B.K., Kumar K.P., and Reich N.C. Interferon regulatory factor 3 and CREB-binding protein/p300 are subunits of double-stranded RNA-activated transcription factor DRAF1. Mol. Cell. Biol. 18 (1998) 1359-1368
52. Sato M., Hata N., Asagiri M., Nakaya T., Taniguchi T., and Tanaka N. Positive feedback regulation of type I IFN genes by the IFN-inducible transcription factor IRF-7. FEBS Lett. 441 (1998) 106-110
53. Sato M., Suemori H., Hata N., Asagiri M., Ogasawara K., Nakao K., Nakaya T., Katsuki M., Noguchi S., Tanaka N., and Taniguchi T. Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-α/β gene induction. Immunity 13 (2000) 539-548